CTD // Fund
Korea-Seoul Life Science Fund
Early & Growth stage life sciences-focused VC firm investing in geographies such as South Korea and the US
← Fund directoryKorea-Seoul Life Science Fund
United StatesKorea-Seoul Life Science Fund is an institutional investor (Conventional VCs) founded in 2011 and headquartered in Seoul, South Korea. Seoul Life Science Fund is an early and growth stage centric venture capital firm. Invests in geographies like South Korea and the US. Typically invests in life sciences sectors such as Biotechnology, Medical Devices, Drugs and Diagnostics. Top investments include ChunLab, Corestem, CrystalGenomis, Earlogic. Notable portfolio companies: ChunLab, Corestem, CrystalGenomis, Earlogic.
- Stage
- seed, early-stage, later-stage, seed, early-stage, later-stage
- Check size
- $2M-$7M
- HQ
- Cambridge, United States
- Founded
- 2011
- Website
- http://kslsfund.com
- LinkedIn
- https://linkedin.com/company/thekorea-seoullifesciencefundkslsf
Institutional Investorbiotechnologydrugsmedical devicesdiagnosticshealthcare serviceshealthcare convergence
What they look for
cross-border life sciences companies; innovative with potential to meet unmet medical needs; clinical-stage or early R&D preferred
📊 Ballpark pre-money for pipeline deals — estimate equity value before you diligence a round.
⚠️ Common pitch mistakes we see →
Preparing to pitch Korea-Seoul Life Science Fund?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →